|
Volumn 6, Issue 4, 2004, Pages 145-147
|
Breast cancer research and the European Union Clinical Trials Directive
|
Author keywords
Clinical trial; European Union; Government; Legislation; Regulation
|
Indexed keywords
TAMOXIFEN;
ACCURACY;
ARTICLE;
BREAST CANCER;
CANCER RESEARCH;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DRUG INDUSTRY;
DRUG SURVEILLANCE PROGRAM;
EUROPEAN UNION;
GOOD CLINICAL PRACTICE;
HEALTH CARE ORGANIZATION;
HUMAN;
INFORMED CONSENT;
LAW;
MEDICAL ETHICS;
BREAST NEOPLASMS;
CLINICAL PROTOCOLS;
CLINICAL TRIALS;
ETHICS COMMITTEES, RESEARCH;
EUROPEAN UNION;
HUMANS;
PRACTICE GUIDELINES;
|
EID: 4344714862
PISSN: 14655411
EISSN: None
Source Type: Journal
DOI: 10.1186/bcr800 Document Type: Article |
Times cited : (6)
|
References (5)
|